Reply by L. Maffioli

Affiliations

¹ Nuclear Medicine Department, A.S.S.T. Ovest Milanese, Via Papa Giovanni Paolo II, Legnano, Milan, 20025, Italy. lsmaffioli@yahoo.com.
² Nuclear Medicine Department, A.S.S.T. Ovest Milanese, Via Papa Giovanni Paolo II, Legnano, Milan, 20025, Italy.
³ Nuclear Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, Milano, 20122, Italy.

Comment

Lorenzo Maffioli et al. Eur J Nucl Med Mol Imaging. 2017 Apr.

. 2017 Apr;44(4):730-731.

doi: 10.1007/s00259-016-3570-7.

¹ Nuclear Medicine Department, A.S.S.T. Ovest Milanese, Via Papa Giovanni Paolo II, Legnano, Milan, 20025, Italy. lsmaffioli@yahoo.com.
² Nuclear Medicine Department, A.S.S.T. Ovest Milanese, Via Papa Giovanni Paolo II, Legnano, Milan, 20025, Italy.
³ Nuclear Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, Milano, 20122, Italy.

No abstract available

Comment on

Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer.
Porter AT, McEwan AJ, Powe JE, Reid R, McGowan DG, Lukka H, Sathyanarayana JR, Yakemchuk VN, Thomas GM, Erlich LE, et al. Porter AT, et al. Int J Radiat Oncol Biol Phys. 1993 Apr 2;25(5):805-13. doi: 10.1016/0360-3016(93)90309-j. Int J Radiat Oncol Biol Phys. 1993. PMID: 8478230 Clinical Trial.